ESR1 and breast carcinoma: In contrast, we previously demonstrated a significant reduction of proliferation in ERα-positive MCF7 human breast cancer cells after siRNA-mediated knockdown of TFF1, similar to the effect of ERα, GREB1 or PR knockdown [51].